He vitiligo is a disease which is characterized by creating Light spots on certain areas of the body. Recently, the European Medicines Agency (EMA) has given its approval for a market to come out cream that reverses vitiligo. Will it be the end of the disease?
People who suffer from this Skin illness, they often have low self-esteem due to bullying or discrimination they experience. Vitiligo can affect young and old, regardless of social class. Among the best known cases are Michael JacksonTamar Braxton o Winnie Harlow.
What is vitiligo?
He vitiligo is a autoimmune disease in which it happens patchy loss of skin colorbecause the cells that produce melanin they are destroyed. This disease can happen at any time, although it usually appears before the age of 30.
According to data, worldwide, it affects approximately 1% of the population. Most patients suffer non segmental vitiligo. This type of vitiligo is more frequent and can affect various parts of the body. It is usually activated by trauma, such as the Koebner phenomenon.
He segmental vitiligo It affects a single area of the body and usually appears at two years of age.
New drug manages to reverse vitiligo. Photo: Getty Images
What’s new for vitiligo?
Until a few months ago, there was no knowledge of any medication that would help curb vitiligo. Fortunately, recently the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has recommended the approval of a cream to treat this disease.
Dr. Steven Stein notes: “As there are currently no centrally approved treatment options in the EU, this positive opinion marks an important milestone for the vitiligo patient community.”
What is the name of the new vitiligo cream?
He medicine in cream is called Ruxolitinib and is used to treat non segmental vitiligo affecting the face in adolescents 12 years of age and adults.
This drug was tested in more than 600 patients to verify its effectiveness. Two clinical trials were carried out: TRuE-V1 and TRuE-V2, to evaluate the product efficacy and safety. The results were published in The New England Journal of Medicine.
According to the results, there were significant improvements in skin pigmentation, within the first 3 months of use of the Ruxolitinib. Although this is good news, the doctors point out that there were some adverse reactions: acne in the area where the cream is applied, nasopharyngitis (infection affecting the nose), urinary infections, headache, erythema (skin reaction), pruritus (itching sensation) or fever.
New drug manages to reverse vitiligo. Photo:
How much does Ruxolitinib cream cost?
He Ruxolitinib price is approximately $2562.04. The next step is for the European Commission to give its approval so that the drug can be marketed. If that is achieved, it will be the first medicine that helps reduce and reverse the effects of vitiligo in people with this disease.
Thierry Passeron, director of the Department of Dermatology at the Université Côte d’Azur, Nice, commented: “I am delighted with the news and I look forward to the approval of an effective treatment to treat the pigmentationwhich will provide a much-needed option for patients with vitiligo and for the clinical community.
You may also like: What did Irma Serrano, La Tigresa, die of?
Although the approval by the European Commission is yet to be made, this medicine is expected to help many people worldwide who suffer from this autoimmune disease.